FMR LLC 13D and 13G filings for Compass Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-02-09 08:50 am Sale | 2024-02-08 | 13G | Compass Therapeutics, Inc. CMPX | FMR LLC | 4,551,506 3.570% | -1,803,308 (-28.38%) | Filing |
| 2023-02-09 08:14 am Sale | 2023-02-09 | 13G | Compass Therapeutics, Inc. CMPX | FMR LLC | 6,354,814 5.035% | -517,600 (-7.53%) | Filing |
| 2022-02-09 09:11 am Purchase | 2022-02-08 | 13G | Compass Therapeutics, Inc. CMPX | FMR LLC | 6,872,414 7.010% | 2,750,000 (+66.71%) | Filing |
| 2021-02-08 10:19 am Purchase | 2021-02-05 | 13G | Compass Therapeutics, Inc. CMPX | FMR LLC | 4,122,414 6.744% | 4,122,414 (New Position) | Filing |